Pharmaceuticals, Biotechnology and Life Sciences
Pivotal Phase 3 EMPOWUR study met both co-primary endpoints, with significant reduction in daily urge urinary incontinence episodes and micturitions,…
Fast Track and Orphan Drug Status; No treatment currently exists for advanced liver cancer patients in whom the current standard…
TORONTO–(BUSINESS WIRE)–lt;a href="https://twitter.com/hashtag/FSDDF?src=hash" target="_blank"gt;#FSDDFlt;/agt;–FSD Pharma Inc. (CSE:HUGE) (OTC:FSDDF) (FRA:0K9) (“FSD Pharma”, “FSD” or “the Company”) today reported its financial and operational results for…
TORONTO–(BUSINESS WIRE)–Acerus Pharmaceuticals Corporation (TSX:ASP) will announce its first quarter 2019 financial and operating results on Monday May 13, 2019…
— First and only medicines approved for patients with either wild-type or hereditary transthyretin amyloid cardiomyopathy — NEW YORK–(BUSINESS WIRE)–Pfizer…
STAMFORD, Conn.–(BUSINESS WIRE)–SpringWorks Therapeutics, Inc., a clinical-stage biopharmaceutical company focused on developing life-changing medicines for patients with severe rare diseases…
Tazemetostat NDA Submissions for Epithelioid Sarcoma and Follicular Lymphoma on Track for Second Quarter and Fourth Quarter 2019, Respectively Updated…
Preliminary Quarterly Revenue Increase of 12.8% Comparable to 2018 Fourth Quarter and Increase of 18.0% Comparable to 2018 First Quarter…
Clinical-stage biotech offering unique access to cell biology images with the goal of driving more effective artificial intelligence methods in…
Use in the Emergency Room demonstrates BrainScope One can reduce patient radiation exposure, decrease use of hospital resources, and shorten…